IHE vs. FXAIX
Compare and contrast key facts about iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity 500 Index Fund (FXAIX).
IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. FXAIX is managed by Fidelity.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IHE or FXAIX.
Performance
IHE vs. FXAIX - Performance Comparison
Returns By Period
In the year-to-date period, IHE achieves a 12.17% return, which is significantly lower than FXAIX's 26.70% return. Over the past 10 years, IHE has underperformed FXAIX with an annualized return of 4.71%, while FXAIX has yielded a comparatively higher 13.12% annualized return.
IHE
12.17%
-3.46%
5.50%
19.15%
8.42%
4.71%
FXAIX
26.70%
3.09%
13.28%
32.84%
15.78%
13.12%
Key characteristics
IHE | FXAIX | |
---|---|---|
Sharpe Ratio | 1.56 | 2.68 |
Sortino Ratio | 2.25 | 3.58 |
Omega Ratio | 1.27 | 1.50 |
Calmar Ratio | 1.69 | 3.89 |
Martin Ratio | 5.37 | 17.48 |
Ulcer Index | 3.57% | 1.88% |
Daily Std Dev | 12.24% | 12.24% |
Max Drawdown | -38.20% | -33.79% |
Current Drawdown | -5.67% | -0.46% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IHE vs. FXAIX - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is higher than FXAIX's 0.02% expense ratio.
Correlation
The correlation between IHE and FXAIX is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
IHE vs. FXAIX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IHE vs. FXAIX - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.55%, more than FXAIX's 1.21% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
iShares U.S. Pharmaceuticals ETF | 1.55% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% | 1.06% |
Fidelity 500 Index Fund | 1.21% | 1.45% | 1.69% | 1.22% | 1.60% | 1.95% | 2.07% | 1.81% | 2.01% | 2.56% | 2.63% | 1.84% |
Drawdowns
IHE vs. FXAIX - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for IHE and FXAIX. For additional features, visit the drawdowns tool.
Volatility
IHE vs. FXAIX - Volatility Comparison
iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 4.42% compared to Fidelity 500 Index Fund (FXAIX) at 3.96%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.